Phosphatidylinositol 3-kinase Regulates Nuclear Translocation of NF-E2-related Factor 2 Through Actin Rearrangement in Response to Oxidative Stress
Overview
Pharmacology
Affiliations
Expression of phase II detoxifying genes is regulated by NF-E2-related factor 2 (Nrf2)-mediated antioxidant response element (ARE) activation. We showed previously that phosphatidylinositol 3 (PI3)-kinase plays an essential role in ARE-mediated rGSTA2 induction by oxidative stress. In view of the fact that the signaling pathway of PI3-kinase controls microfilaments and translocation of actin-associated proteins, the current study was designed to investigate the PI3-kinase-mediated nuclear translocation of Nrf2 and the interaction of Nrf2 with actin. tert-Butylhydroquinone (t-BHQ) caused Nrf2 to translocate into the nucleus in H4IIE cells, which was prevented by pretreatment of the cells with PI3-kinase inhibitors (wortmannin/LY294002). t-BHQ relocalized Nrf2 in concert with changes in actin microfilament architecture, as visualized by superposition of immunochemically stained Nrf2 and fluorescent phalloidin-stained actin. Furthermore, t-BHQ increased the level of nuclear actin, coimmunoprecipitated with Nrf2, which returned to that of control by pretreatment of the cells with PI3-kinase inhibitors. Cytochalasin B, an actin disruptor, alone stimulated actin-mediated nuclear translocation of Nrf2 and induced rGSTA2. In contrast, phalloidin, an agent that prevents actin filaments from depolymerization, inhibited Nrf2 translocation and rGSTA2 induction by t-BHQ. Subcellular fractionation and immunoblot analyses allowed us to detect both 57- and 100-kDa Nrf2. Immunoblot and immunoprecipitation assays showed that the 100-kDa protein comprised both Nrf2 and actin. The present study demonstrates that the PI3-kinase signaling pathway regulates rearrangement of actin microfilaments in response to oxidative stress and that depolymerization of actin causes a complex of Nrf2 bound with actin to translocate into nucleus.
Kumar R, Kumari P, Kumar R Mol Neurobiol. 2025; .
PMID: 39875779 DOI: 10.1007/s12035-025-04712-z.
Si L, An Y, Zhou J, Lai Y Heliyon. 2025; 11(1):e41002.
PMID: 39758400 PMC: 11699331. DOI: 10.1016/j.heliyon.2024.e41002.
Haider S, Chakraborty S, Chowdhury G, Chakrabarty A ACS Pharmacol Transl Sci. 2024; 7(5):1237-1251.
PMID: 38751638 PMC: 11091984. DOI: 10.1021/acsptsci.3c00279.
The promising antioxidant effects of lignans: Nrf2 activation comes into view.
Hassanein E, Althagafy H, Baraka M, Abd-Alhameed E, Ibrahim I, El-Maksoud M Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):6439-6458.
PMID: 38695909 PMC: 11422461. DOI: 10.1007/s00210-024-03102-x.
Rosario-Rodriguez L, Cantres-Rosario Y, Carrasquillo-Carrion K, Rodriguez-De Jesus A, Cartagena-Isern L, Garcia-Requena L Int J Mol Sci. 2024; 25(6).
PMID: 38542221 PMC: 10970132. DOI: 10.3390/ijms25063246.